$PRTA
PROTHENA CORP PUBLIC LTD CO

2013 Q4 Form 10-Q Financial Statement

#000155905313000010 Filed on November 12, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q4
Revenue $167.0K $171.0K $560.0K
YoY Change -70.18% -82.9% 460.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.270M $3.390M $2.930M
YoY Change 79.86% 61.43% 109.29%
% of Gross Profit
Research & Development $5.600M $6.348M $9.840M
YoY Change -43.09% -15.7% 18.55%
% of Gross Profit
Depreciation & Amortization $230.0K $100.0K $270.0K
YoY Change -14.81% 0.0% -370.0%
% of Gross Profit
Operating Expenses $10.87M $9.737M $12.80M
YoY Change -15.05% 1.3% 31.91%
Operating Profit -$9.566M
YoY Change 10.36%
Interest Expense $20.00K $10.00K $10.00K
YoY Change 100.0%
% of Operating Profit
Other Income/Expense, Net -$230.0K $14.00K
YoY Change
Pretax Income -$10.91M -$9.552M -$12.21M
YoY Change -10.65% 10.2% 27.19%
Income Tax $150.0K $137.0K $10.00K
% Of Pretax Income
Net Earnings -$11.05M -$9.689M -$12.22M
YoY Change -9.55% 11.78% 25.99%
Net Earnings / Revenue -6619.16% -5666.08% -2182.32%
Basic Earnings Per Share -$0.55
Diluted Earnings Per Share -$515.9K -$0.55 -$836.9K
COMMON SHARES
Basic Shares Outstanding 21.86M shares 17.68M shares
Diluted Shares Outstanding 17.68M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $176.7M $101.9M $124.9M
YoY Change 41.47%
Cash & Equivalents $176.7M $101.9M $124.9M
Short-Term Investments
Other Short-Term Assets $1.500M $1.100M $800.0K
YoY Change 87.5% 1000.0% 700.0%
Inventory
Prepaid Expenses
Receivables $0.00 $100.0K $200.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $178.2M $102.9M $125.8M
YoY Change 41.62% 102838.0% 125741.0%
LONG-TERM ASSETS
Property, Plant & Equipment $3.372M $3.581M $3.442M
YoY Change -2.03% 43.24% 37.68%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $739.0K $0.00
YoY Change -17.89% -100.0%
Total Long-Term Assets $4.188M $4.998M $3.442M
YoY Change 21.67% 42.8% -1.66%
TOTAL ASSETS
Total Short-Term Assets $178.2M $102.9M $125.8M
Total Long-Term Assets $4.188M $4.998M $3.442M
Total Assets $182.4M $107.9M $129.3M
YoY Change 41.09% 2898.22% 3491.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.790M $896.0K $0.00
YoY Change 796.0% -100.0%
Accrued Expenses $4.400M $4.800M $1.600M
YoY Change 175.0% 6.67% -79.22%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.406M $7.715M $1.744M
YoY Change 324.66% 60.73% -79.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.700M $1.400M $1.100M
YoY Change 54.55% -26.32% -35.29%
Total Long-Term Liabilities $1.734M $1.400M $1.100M
YoY Change 57.64% -26.32% -35.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.406M $7.715M $1.744M
Total Long-Term Liabilities $1.734M $1.400M $1.100M
Total Liabilities $9.140M $9.155M $2.799M
YoY Change 226.55% 36.64% -72.29%
SHAREHOLDERS EQUITY
Retained Earnings -$41.34M -$30.29M -$345.0K
YoY Change 11882.9%
Common Stock $219.0K $177.0K $177.0K
YoY Change 23.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $173.3M $98.78M $126.5M
YoY Change
Total Liabilities & Shareholders Equity $182.4M $107.9M $129.3M
YoY Change 41.09% 2898.22% 3491.19%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q4
OPERATING ACTIVITIES
Net Income -$11.05M -$9.689M -$12.22M
YoY Change -9.55% 11.78% 25.99%
Depreciation, Depletion And Amortization $230.0K $100.0K $270.0K
YoY Change -14.81% 0.0% -370.0%
Cash From Operating Activities -$9.840M -$10.30M -$15.47M
YoY Change -36.39% 35.35% 186.48%
INVESTING ACTIVITIES
Capital Expenditures $10.00K -$230.0K -$1.100M
YoY Change -100.91% 666.67% 266.67%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 -$230.0K -$1.100M
YoY Change -100.0% 666.67% 266.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 84.65M -120.0K 141.4M
YoY Change -40.15% -101.57% 2381.23%
NET CHANGE
Cash From Operating Activities -9.840M -10.30M -15.47M
Cash From Investing Activities 0.000 -230.0K -1.100M
Cash From Financing Activities 84.65M -120.0K 141.4M
Net Change In Cash 74.81M -10.65M 124.9M
YoY Change -40.08% 571767521279999800.0% 4468913471487997000.0%
FREE CASH FLOW
Cash From Operating Activities -$9.840M -$10.30M -$15.47M
Capital Expenditures $10.00K -$230.0K -$1.100M
Free Cash Flow -$9.850M -$10.07M -$14.37M
YoY Change -31.45% 32.85% 181.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
0 USD
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
896000 USD
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
27000 USD
CY2013Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
617000 USD
CY2013Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
384000 USD
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-169000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
73000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
23000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
50000 USD
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
27000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3743000 USD
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4053000 USD
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
128891000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
126652000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2037000 USD
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
955000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1424000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1930000 shares
CY2013Q3 us-gaap Assets
Assets
107936000 USD
CY2012Q4 us-gaap Assets
Assets
129283000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
125841000 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
102938000 USD
CY2012Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3442000 USD
CY2013Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
4998000 USD
CY2012Q4 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
0.18
CY2013Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
85000 USD
CY2012Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
85000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
101859000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
124860000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-23001000 USD
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17679182 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17679182 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17679182 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17679182 shares
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
177000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
177000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-586000 USD
CY2012Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0 USD
CY2013Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
-493000 USD
CY2012Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
51000 USD
CY2013Q3 us-gaap Deferred Rent Credit
DeferredRentCredit
96000 USD
CY2013Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1440000 USD
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1055000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
73000 USD
CY2013Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
267000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
0 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.01
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
567000 USD
CY2013Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
678000 USD
CY2012Q3 us-gaap Depreciation
Depreciation
100000 USD
us-gaap Depreciation
Depreciation
400000 USD
us-gaap Depreciation
Depreciation
300000 USD
CY2013Q3 us-gaap Depreciation
Depreciation
100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
306000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
428000 USD
CY2013Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
54000 USD
CY2012Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
223000 USD
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.55
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.69
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1716000 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1592000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
29000 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3389000 USD
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2082000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9782000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6967000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8668000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-29675000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9552000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-29190000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
267000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
137000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
263000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3263000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5734000 USD
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
0 USD
CY2012Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
0 USD
CY2013Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
14000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
0 USD
CY2013Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1927000 USD
CY2012Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1651000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
2799000 USD
CY2013Q3 us-gaap Liabilities
Liabilities
9155000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
129283000 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
107936000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1744000 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7715000 USD
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
5449000 USD
CY2013Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
5622000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26711000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-201000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-274000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-538000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26437000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22262000 USD
us-gaap Net Income Loss
NetIncomeLoss
-29942000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-8668000 USD
us-gaap Net Income Loss
NetIncomeLoss
-29190000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-9689000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
9737000 USD
us-gaap Operating Expenses
OperatingExpenses
31273000 USD
us-gaap Operating Expenses
OperatingExpenses
30234000 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
9612000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-29725000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8668000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-29190000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9566000 USD
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
739000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1670000 USD
CY2013Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3085000 USD
CY2012Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
0 USD
CY2013Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
396000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
117000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
274000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
685000 USD
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
758000 USD
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
0 USD
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
26711000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
29000 USD
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7634000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7185000 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3581000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3442000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20452000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24306000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7530000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6348000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30287000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-345000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
509000 USD
CY2012Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
944000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
2083000 USD
CY2013Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
171000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
5733000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2037000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
98781000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
126484000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Because of the uncertainties inherent in such estimates, actual results may differ materially from these estimates.</font></div></div>
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17679000 shares
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14497000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17679000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14497000 shares
CY2012Q4 prta Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
47000 USD
CY2013Q3 prta Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
3117000 USD
CY2012Q3 prta Centralized Support Cost
CentralizedSupportCost
1800000 USD
prta Centralized Support Cost
CentralizedSupportCost
5800000 USD
CY2013Q3 prta Deferred Shares Par Value
DeferredSharesParValue
22
CY2012Q4 prta Deferred Shares Par Value
DeferredSharesParValue
22
CY2013Q3 prta Deferred Shares Share Issued
DeferredSharesShareIssued
0 shares
CY2012Q4 prta Deferred Shares Share Issued
DeferredSharesShareIssued
0 shares
CY2012Q4 prta Deferred Shares Share Outstanding
DeferredSharesShareOutstanding
0 shares
CY2013Q3 prta Deferred Shares Share Outstanding
DeferredSharesShareOutstanding
0 shares
CY2012Q4 prta Deferred Shares Shares Authorized
DeferredSharesSharesAuthorized
10000 shares
CY2013Q3 prta Deferred Shares Shares Authorized
DeferredSharesSharesAuthorized
10000 shares
CY2012Q4 prta Deferred Shares Value
DeferredSharesValue
0 USD
CY2013Q3 prta Deferred Shares Value
DeferredSharesValue
0 USD
prta Post Separation Adjustments To Funding Provided By Related Party
PostSeparationAdjustmentsToFundingProvidedByRelatedParty
0 USD
prta Post Separation Adjustments To Funding Provided By Related Party
PostSeparationAdjustmentsToFundingProvidedByRelatedParty
84000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001559053
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21856261 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
Prothena Corp plc
dei Trading Symbol
TradingSymbol
PRTA

Files In Submission

Name View Source Status
0001559053-13-000010-index-headers.html Edgar Link pending
0001559053-13-000010-index.html Edgar Link pending
0001559053-13-000010.txt Edgar Link pending
0001559053-13-000010-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
prta-20130930.xml Edgar Link completed
prta-20130930.xsd Edgar Link pending
prta-20130930_cal.xml Edgar Link unprocessable
prta-20130930_def.xml Edgar Link unprocessable
prta-20130930_lab.xml Edgar Link unprocessable
prta-20130930_pre.xml Edgar Link unprocessable
prta2013q310-qxex311.htm Edgar Link pending
prta2013q310-qxex312.htm Edgar Link pending
prta2013q310-qxex321.htm Edgar Link pending
prta2013q310q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending